Page 34 - Glucose Monitoring Devices

References 29

[101] Recommendations j Type 2 diabetes in adults: management j Guidance j NICE.
Nice.Org.Uk; 2015. Available from: https://www.nice.org.uk/guidance/ng28/chapter/
1-recommendations#individualised-care. [Accessed 1 June 2019].
[102] IDF clinical practice recommendations for managing Type 2 diabetes in primary care.
Idf.Org.; 2017. Available from: https://www.idf.org/e-library/guidelines/128-idf-
clinical-practice-recommendations-for-managing-type-2-diabetes-in-primary-care.
html. [Accessed 1 June 2019].
[103] Berard L, Siemens R, Woo V. Monitoring glycemic control. Canadian Journal of Dia-
betes 2018;42:S47e53. https://doi.org/10.1016/j.jcjd.2017.10.007.
[104] Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Idf.Org; 2009.
Available from: https://www.idf.org/e-library/guidelines/85-self-monitoring-of-blood-
glucose-in-non-insulin-treated-type-2-diabetes.html. [Accessed 1 June 2019].
[105] Guideline for management of post meal glucose in diabetes. Idf.Org; 2011. Available
from: https://www.idf.org/e-library/guidelines/82-management-of- postmeal-glucose.
html. [Accessed 1 June 2019].
[106] Woerle H, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, et al. Impact of fast-
ing and postprandial glycemia on overall glycemic control in type 2 diabetes. Diabetes
Research and Clinical Practice 2007;77:280e5. https://doi.org/10.1016/
j.diabres.2006.11.011.
[107] Schnell O, Alawi H, Battelino T, Ceriello A, Diem P, Felton A, et al. Addressing
schemes of self-monitoring of blood glucose in type 2 diabetes: a European perspec-
tive and expert recommendation. Diabetes Technology and Therapeutics 2011;13:
959e65. https://doi.org/10.1089/dia.2011.0028.
[108] O’Connell M, Donath S, Cameron F. Poor adherence to integral daily tasks limits the
efficacy of CSII in youth. Pediatric Diabetes 2011. https://doi.org/10.1111/j.1399-
5448.2010.00740.x.
[109] Miller K, Foster N, Beck R, Bergenstal R, DuBose S, DiMeglio L, et al. Current state
of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic
registry. Diabetes Care 2015;38:971e8. https://doi.org/10.2337/dc15-0078.
[110] Foster N, Beck R, Miller K, Clements M, Rickels M, DiMeglio L, et al. State of type 1
diabetes management and outcomes from the T1D Exchange in 2016e2018. Diabetes
Technology and Therapeutics 2019;21:66e72. https://doi.org/10.1089/dia.2018.0384.
[111] Mostro ¨m P, Ahle ´n E, Imberg H, Hansson P, Lind M. Adherence of self-monitoring of
blood glucose in persons with type 1 diabetes in Sweden. British Medical Journal
Open Diabetes Research and Care 2017;5:e000342. https://doi.org/10.1136/bmjdrc-
2016-000342.
[112] Rossi M, Lucisano G, Ceriello A, Mazzucchelli C, Musacchio N, Ozzello A, et al.
Real-world use of self-monitoring of blood glucose in people with type 2 diabetes:
an urgent need for improvement. Acta Diabetologica 2018;55:1059e66. https://
doi.org/10.1007/s00592-018-1186-z.
[113] Vincze G, Barner J, Lopez D. Factors associated with adherence to self-monitoring of
blood glucose among persons with diabetes. The Diabetes Educator 2004;30:112e25.
https://doi.org/10.1177/014572170403000119.
[114] Fisher W, Kohut T, Schachner H, Stenger P. Understanding self-monitoring of blood
glucose among individuals with type 1 and type 2 diabetes. The Diabetes Educator
2011;37:85e94. https://doi.org/10.1177/0145721710391479.
[115] Patton S. Adherence to glycemic monitoring in diabetes. Journal of Diabetes Science
and Technology 2015;9:668e75. https://doi.org/10.1177/1932296814567709.